The Venture Codex

Participated · Convertible Note · Aug 2026

Shape Memory Medical develops a proprietary shape memory polymer platform intended for endovascular embolization; the low-density, highly porous material is delivered compressed via catheter and self-expands upon contact with blood to promote organized thrombus formation and adapt to complex vascular anatomy. The company’s IMPEDE and IMPEDE-FX Embolization Plugs and IMPEDE-FX RapidFill have CE Mark approval, the IMPEDE products are approved in Japan and cleared for use in the United States, and IMPEDE-FX RapidFill is investigational in the U.S. Its technology has been used in more than 3,500 patients and its products have regulatory approvals in more than 40 countries. Building on its commercial embolization platform, Shape Memory Medical is expanding into aortic indications through clinical programs including the randomized AAA-SHAPE Pivotal Trial (now fully enrolled) and the FLAGSHIP first-in-human study for false lumen embolization. The company is using recent financing to advance these clinical programs, collect follow-up data, and support broader adoption of the platform.

Participated · Series A · Jul 2026

Founded in 2019, Luxonis develops the OAK camera family and the open-source DepthAI software to provide on-device visual perception for robotics and automated systems. The company’s DepthAI SDK has reached 6 million downloads and it serves thousands of customers, including more than 60 Fortune 500 companies and 17 of the Dow Jones 30. Luxonis plans to deepen the OAK4 platform, scale production, and introduce new devices at accessible price points and flexible form factors. The company intends to expand R&D, go-to-market, and engineering-support teams to accelerate production deployments. Having raised a $14 million Series A, Luxonis aims to broaden supply-chain capacity and advance edge AI architectures to make its platform easier to adopt.

Participated · Series A · May 2026

Havoc develops an all-domain collaborative autonomy stack and a software-defined hardware approach that enables heterogeneous autonomous assets to sense, decide, and act together across sea, air, and land. The company reports more than 25,000 hours of autonomous testing and deployments and has collected over 200 billion data points from operations to iterate its field-tested autonomy stack. Havoc has built and deployed 100+ autonomous surface vessels (ASVs) globally, with 40+ mission-ready today and 30+ vessels delivered to the U.S. Department of Defense. It has made strategic acquisitions (Mavrik and Teleo) to expand into air and land domains and maintains partnerships with defense primes such as Leidos, Lockheed Martin, and SAIC as well as shipbuilders and additive manufacturers. Havoc has grown to over 200 employees, opened new offices in Austin and San Diego, and expanded maritime production in Rhode Island. The company highlights award recognition, SBIR awards, and selection to industry challenges as validation while positioning itself to scale deployments and production to meet defense and commercial demand.

Participated · Equity · May 2026

Founded in 2009, Skeleton Technologies develops supercapacitor-based energy storage systems built on its patented Curved Graphene technology and claims to be the world’s largest manufacturer of supercapacitors for mission-critical infrastructure. Its flagship offering, GrapheneGPU, is targeted at high-density AI computing environments and the company says it reduces energy consumption by 40% while increasing computing power by 40%. Skeleton operates mass-scale manufacturing in Germany and a one-gigawatt SuperBattery factory in Finland and is preparing to expand production to the United States. The company holds protection through 70 patent families and says it now has the largest engineering and R&D teams in the high-power energy storage sector. Financially, the firm has raised a total of €392 million in venture capital ahead of a planned U.S. IPO in 2027.

Led · Series B · Apr 2026

Alcatraz develops the Rock™, an AI-driven physical access control solution that authenticates people as they walk past entry points without taking photographs or storing biometric images. The company positions its technology as privacy-first facial authentication (not surveillance), designed to meet GDPR, CCPA, BIPA, and other compliance requirements. Its customers include leading AI data centers, major U.S. airports, energy companies, Fortune 100 enterprises, NFL teams, and top universities. In 2025 the company reported rapid adoption metrics: more than 300% year-over-year growth in data center adoption, 200% growth in new enterprise customers, and a fivefold expansion across Fortune 500 deployments. Alcatraz has raised over $100 million in total capital and plans to use the new funding to expand into new verticals and international markets and to grow its team.